Scientists present 5-year phase II data on odanacatib in postmenopausal women with low BMD Sep. 27, 2011
Scientists present phase II data on TAS-102 in CRC and potential predictors of efficacy Sep. 27, 2011
Phase II/III data on antidiabetic efficacy of insulin degludec and insulin degludec/insulin aspart Sep. 27, 2011
Phase II trial evaluates DCE-US to monitor response to TKI-258 therapy in renal cell carcinoma Sep. 26, 2011
Phase I data on Ad26.ENVA.01 in HAdV-26-seronegative and -seropositive HIV-1-uninfected adults Sep. 23, 2011
RSS